OLOPATADINE HYDROCHLORIDE
NDC 68001-530, OLOPATADINE HYDROCHLORIDE, solution, from BluePoint Laboratories.
- Product NDC
- 68001-530
- Status
- Listed
- Labeler
- BluePoint Laboratories
- Dosage form
- SOLUTION
- Route
- OPHTHALMIC
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA209995
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68001-530 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- OLOPATADINE HYDROCHLORIDE2 mg/mL
Pharmacologic classes
Decreased Histamine Release [PE]; Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]; Histamine-1 Receptor Inhibitor [EPC]; Mast Cell Stabilizer [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68001-530-69 | 68001053069 | 1 BOTTLE, PLASTIC in 1 CARTON (68001-530-69) / 2.5 mL in 1 BOTTLE, PLASTIC |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
NADAC price for package 68001053069
GET /v1/drugs/nadac/68001053069
Use it
Look up 68001-530 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68001-530 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68001-530. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.